Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study.
Damian MeyersburgTobias WelponerAndreas KaiserSylvia SelhoferRafaella TatarskiAlessandra HandisuryaJohannes Wolfgang BauerPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Topical BB and oral ivermectin have shown comparable good therapeutic efficacy. Therefore, both agents constitute an adequate first-line therapy in the treatment of scabies. A combination of both agents may be considered in recalcitrant and extensively infested cases, additionally to crusted scabies.